TargetMol Chemicals Inc.

Firmenname:TargetMol Chemicals Inc.

Telefon:-

E-Mail:marketing@targetmol.com

Nationalität:China

Produkte insgesamt:19711

72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176

Produktkatalog

PLH2058		2525206-41-9
Theralizumab		906068-56-2
Endo-1,3-β-glucanase		9025-37-0
A2B receptor antagonist 2 hydrochloride		724-70-9	C12H15N5.ClH
FC-116		2417298-29-2
Angiotensin 1/2 (1-9) TFA
BCAT-IN-4		406190-85-0
P-gb-IN-1		2632874-49-6
Senktide acetate
[Sar1, Ile8]-Angiotensin II 3TFA		37827-06-8	C46H73N13O10
DSPE-NHS		1383932-86-2	C49H89N2O13P
MitoSOX Red		1003197-00-9	C43H43IN3P
APOBEC3G-IN-1		14261-92-8	C15H11NO3
AUTAC1		2241669-09-8
CLK8		898920-65-5	C29H26N2O6
SOS1-IN-15		2793404-47-2	C28H27F3N6O2
CpG ODN 10101		1234402-77-7
JNJ-49095397		1220626-82-3	C34H36N6O4
(Rac)-SHIN2		2204289-53-0	C23H26N4O3
CZL55		667408-87-9	C20H22N2O6
ccc_R08		2919019-72-8	C22H19ClO6
DC-BPi-03		2758411-46-8	C14H14N4O2S
SMN-C2		1446311-56-3	C24H27N5O2
MyD88-IN-1		2911609-80-6	C23H24N6O7S
SID-852843		909859-19-4	C17H15N3O5S
GSK3-IN-3		331963-27-0	C24H35N3O4
[Leu5]-Enkephalin acetate(58822-25-6 free base)	N-[N-[N-(N-L-Tyrosylglycyl)glycyl]-L-phenylalanyl]-L-leucin	58822-25-6	C28H37N5O7
SF-22		824981-55-7	C28H26N2O3S
SARS-CoV-2-IN-39		2882823-03-0
TNF-α-IN-9		2054199-25-4	C17H14O4
BCPA		547731-67-9	C22H22Cl2N2O2
PDCD4-IN-1		494763-64-3	C12H9BrClN3O
PLH1215		1332084-64-6
Myosin V-IN-1		1259177-59-7	C29H26N6O3S
SFI003		2361332-90-1	C19H17N5OS
PU.1-IN-1		873588-27-3	C18H22N2O2S
Xanthine oxidoreductase-IN-3		651769-78-7	C14H10ClN5O
hCAII-IN-9		2878477-18-8	C15H16ClN3O5S2
PRMT6-IN-3		2890765-10-1	C19H26N4O2S
PARP-2-IN-3		2915650-86-9
P 218		1142407-60-0	C18H25ClN4O4
BPDA2		2907659-86-1
TJ08		2924274-19-9
Moiramide B		155233-31-1	C25H31N3O5
Pincainide		83471-41-4	C16H24N2O
(R)-HH2853		2202678-06-4	C31H36F3N7O3
GSNKGAIIGLM(131602-53-4(free base))		131602-53-4	C45H81N13O14S
NSC243928 mesylate		59988-01-1
CYP4A11/CYP4F2-IN-1		502654-40-2	C15H15N3OS
Nampt activator-2		2237268-90-3	C17H15ClN4O3S
TGFβ1-IN-3		2883813-58-7
Akt3 degrader 1		2836342-69-7	C53H72N8O4
RSH-7		2764609-97-2	C22H25FN8O
AC 7739		162705-22-8	C18H21NO4.ClH
AXL-IN-13		2376928-82-2	C34H41FN6O5
Larotinib		1438072-11-7	C24H26ClFN4O4
Cbl-b-IN-5		2368835-59-8	C17H17N5OS
Zilovertamab		1643432-38-5
Inotuzumab		1660159-36-3
Brentuximab		2088770-90-3
Glembatumumab vedotin		1182215-65-1
Bivatuzumab		214559-60-1
Cibisatamab		1855925-27-7
Sonepcizumab		1031360-18-5
lorvotuzumab		339306-30-8
Enfortumab		1448664-46-7
Ordesekimab		879293-15-9
GRGDSPK acetate		144027-77-0
OTUB1/USP8-IN-1		2858800-98-1	C22H16ClFN2O4
Clivatuzumab		1622075-09-5
pCDPK1/TgCDPK1-IN-3		1092788-87-8	C17H18N6
USP28-IN-3		2931509-14-5
NP10679		2914889-88-4
TV 3279		209394-29-6	C16H20N2O2
AP-C2		682793-07-3	C18H16N4S
TGFβ1-IN-2		2700263-58-5	C23H30N4O4S
p53 Activator 7		2849340-59-4	C27H32F3N4OP
CYP1B1-IN-5		176442-56-1	C14H8INO2
ENT-C225		2919962-53-9
Dazostinag disodium		2553413-93-5	C21H23F2N8NaO10P2S2
STING agonist-30		2951078-67-2
Ebaresdax hydrochloride		1334385-87-3	C12H15ClN2O3S
Atibeprone		153420-96-3	C17H18N2O3S
SRI-42127		2727872-68-4	C19H20N6O
GW297361		388627-21-2	C16H12N4O3S2
ZIM		301298-87-3	C20H19N3O3
Xanthine oxidoreductase-IN-5		1026652-90-3	C17H17N5O2
PF-17		2697145-21-2	C21H28N4O5S
Nurr1 agonist 2		742058-34-0	C18H14O3S
HDAC-IN-57		2716217-79-5	C21H19N3O4
DATPT		2891582-75-3	C24H38N6O3.ClH
(R)-BI-2852		2375482-49-6	C31 H28 N6 O2
11β-HSD1 inibitor 19		946400-19-7	C19H16ClF4N3O2S
PCSK9-IN-10		368434-98-4	C18H23N5O4
R 59-022 hydrochloride		93076-98-3	C27H27ClFN3OS
STC314		186295-19-2	C13H25NaO32S7
RSS0680		2769753-48-0	C52H64N10O6S3
PARP1/2/TNKS1/2-IN-1		2243453-32-7
HA5		2378406-17-6	C15H10O5
DPTN dihydrochloride		325767-87-1	C22H18N4OS.2ClH